NewsDecember 1
Announcement of New Assignment of Corporate Officer at PHC Holdings Corporation Effective January 1, 2023
Please be advised that the following change will take place at PHC Holdings Corporation (headquarters: Minato-ku, Tokyo).
1. New Assignment on January 1, 2023
| Position/Title |
Name |
Remarks |
Corporate Officer
Co-head of Diagnostics & Life Sciences Domain |
Steven Lynum |
President, Epredia Holdings Ltd. |
2. Corporate Officers at PHC Holdings Corporation on January 1, 2023
| Position/Title |
Name |
Role and Responsibilities |
| Chief Executive Officer (CEO) |
Shoji Miyazaki |
Group Management, Internal Audit |
| Chief Operating Officer (COO) |
Koichiro Sato |
Business Domains, Technology,
Manufacturing, Procurement, Risk Management |
Senior Executive Corporate Officer
Chief Administrative Officer (CAO)
Chief Human Resources Officer (CHRO)
Chief Transformation Officer (CTO) |
Ryuichi Hirashima |
General Affairs, Human Resources, Legal & Compliance, Intellectual Property, Transformation |
Executive Corporate Officer
Chief Financial Officer (CFO) |
Frederick Reidenbach |
Corporate Accounting, Corporate Finance,
Information Technology |
Executive Corporate Officer
Chief Strategy Officer (CSO) |
Kaiju Yamaguchi |
Corporate Strategy,
Business Development, Investor Relations, Corporate Communications, Medical Policy & Public Affairs |
| Corporate Officer |
Robert Schumm |
Head of Diabetes Management Domain
President,
Ascensia Diabetes Care Holdings AG |
| Corporate Officer |
Kyoji Morimoto |
Technology/Manufacturing
President,
PHC Corporation |
| Corporate Officer |
Nobuaki Nakamura |
Co-head of Diagnostics & Life Sciences Domain
Director, Member of Board
Biomedical Division, PHC Corporation |
| Corporate Officer |
Takayuki Otsuka |
Co-head of Healthcare Solutions Domain
Director, Member of Board
Medical Information Systems Division,
PHC Corporation |
| Corporate Officer |
Haruo Watanabe |
Co-head of Healthcare Solutions Domain
President and Chief Executive Officer,
LSI Medience Corporation |
| Corporate Officer |
Steven Lynum |
Co-head of Diagnostics & Life Sciences Domain
President, Epredia Holdings Ltd. |